Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 344-346 , September 2002

Usefulness of captopril renography to predict the benefits of renal artery revascularization or captopril treatment in hypertensive patients with diabetic nephropathy

  • Cheng-Chieh Lin

      Affiliations

    • Department of Family Medicine, China Medical College Hospital, Taichung, Taiwan
    • Department of Medical Research, China Medical College Hospital, No. 2, Yun-Der Road, Taichung 404, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886-4-22052121x6079; fax: +886-4-22064888
    • ,
  • Yu-Chien Shiau

      Affiliations

    • Department of Nuclear Medicine, Far Eastern Memorial Hospital and Institute of Biomedical Engineering, College of Electrical Engineering, National Taiwan University, Taipei, Taiwan
    • ,
  • Tsai-Chung Li

      Affiliations

    • Institute of Chinese Medicine, China Medical College, Taichung, Taiwan
    • ,
  • Albert Kao

      Affiliations

    • Department of Medical Research, China Medical College Hospital, No. 2, Yun-Der Road, Taichung 404, Taiwan
    • ,
  • Cheng-Chun Lee

      Affiliations

    • Department of Medical Research, China Medical College Hospital, No. 2, Yun-Der Road, Taichung 404, Taiwan

Received 4 March 2002 ,Accepted 9 April 2002.

References 

  1. Bakris LG. Angiotensin-converting enzyme inhibitors and progression of diabetic nephropathy (Editorial). Annals of Internal Medicine. 1993;118:643–644
  2. Chaiwatanarat T, Padhy AK, Bomanji J, Nimmon CC, Sonmezoglu K, Britton KE. Validation of renal output efficiency as an objective quantitative parameter in the evaluation of upper urinary tract obstruction. Journal of Nuclear Medicine. 1993;34:845–848
  3. Cohen JJ, Harrington JT, Madias NE. ACE inhibitors in renal disease. Kidney International. 1992;42:463–479
  4. Fommei E, Ghione S, Hilson AJW, Mezzasalma L, Oei HY, Piepsz A, et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study. European Journal of Nuclear Medicine. 1993;20:617–623
  5. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of Tc-99m DTPA (stannous). AJR, American Journal of Roentgenology. 1982;138:565–570
  6. Kumar, V., Cotran, R. S., & Robbins, S. L. (Eds.) (1992). Basic pathology (5th ed.) (pp. 437–472, 569–588). Philadelphia, PA: W.B. Saunders.
  7. Mann SJ, Pickering TG. Detection of renovascular hypertension. State of the art: 1992. Annals of Internal Medicine. 1992;117:845–853
  8. Nally IV, Black HR. State-of-the-art review: captopril renography—pathophysiological considerations and clinical observations. Seminars in Nuclear Medicine. 1992;22:85–97
  9. National Health Department, Taiwan (1977). Annual Vital Statistics.
  10. National Health Department, Taiwan (2000). Annual Vital Statistics.
  11. National Health Insurance Bureau, Taiwan (1998). Statistics Report.
  12. Taylor AT, Fletcher JW, Nally JV, Blaufox MD, Dubovsky EV, Fine EJ. Procedure guideline for diagnosis of renovascular hypertension. Journal of Nuclear Medicine. 1998;39:1297–1302
  13. Valabhji J, Robinson S, Poulter C, Robinson AC, Kong C, Henzen C, et al. Prevalence of renal artery stenosis in subjects with Type 2 diabetes and coexistent hypertension. Diabetes Care. 2000;23:539–543

PII: S1056-8727(02)00182-4

Journal of Diabetes and Its Complications
Volume 16, Issue 5 , Pages 344-346 , September 2002

Article Tools

* Image Usage & Resolution